Topline Results from GALACTIC-HF, Phase 3 Clinical Trial of Omecamtiv Mecarbil, Cardiac Myosin Activator, Expected in Q4 Licensing Collaboration and Royalty Monetization Deals with Xi Jing Pharmaceuticals and RTW Investments Accelerate and Expand Development of CK-3773274, Next Generation Cardiac Myosin Inhibitor Leveraging Partnerships to Finance Build of Commercial Business SOUTH SAN FRANCISCO, […]
Coronary/Structural Heart
Venus Medtech to Partner with Pi-Cardia to Bring its Leaflex(TM) Aortic Valve Technology to China
HANGZHOU, China and REHOVOT, Israel, July 14, 2020 /PRNewswire/ — Venus Medtech (Hangzhou) Inc. (stock code: 2500.HK), the leading transcatheter heart valve medical device player in China, and Pi-Cardia Ltd., a global leader in the development of non-implant catheter-based solutions for treating heart valve calcification, announced today a collaboration to bring Pi-Cardia’s Leaflex™ technology to China. Pi-Cardia’s […]
SINOMED® Completes One-Year Follow-Up of the PIONEER-III European, US and Japanese Trial of the BuMA Supreme® Coronary Drug-Eluting Stent
TIANJIN, China, July 13, 2020 /PRNewswire/ — SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III, randomized global trial evaluating the BuMA Supreme Drug-Eluting Coronary Stent (DES). Once completed, the company plans to submit the data to the U.S. Food and Drug […]
Neovasc Announces Circulatory System Devices Panel Meeting Date for Neovasc Reducer™ Device
VANCOUVER and MINNEAPOLIS, July 09, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), announced today that it has been informed by the U.S. Food and Drug Administration (FDA) that the Circulatory System Devices Panel of the Medical Devices Advisory Committee will review the premarket approval application (PMA) for […]
Somalogic and NEC Solution Innovators Announce Launch of Foneslife Corporation
New company will deliver blood tests based on large-scale protein measurements to people in Japan BOULDER, Colo., July 09, 2020 (GLOBE NEWSWIRE) — SomaLogic, Inc. and NEC Solution Innovators, Ltd. of Japan, a subsidiary of NEC Corporation, announced today the establishment of FonesLife Corporation, a new Tokyo-based company that will […]
Philips and BioIntelliSense form strategic collaboration to enhance remote patient monitoring for at-risk patients from the hospital into the home
July 9, 2020 Philips integrates the BioIntelliSense FDA-cleared BioSticker™ sensor as part of its remote patient monitoring solutions for patients outside the hospital Multi-parameter sensors aid monitoring across multiple chronic conditions with medical-grade vital signs for physicians to remotely track core symptoms, including COVID-19 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, […]
Nonin Medical Announces FDA Clearance of the CO-Pilot™ Wireless Handheld Multi-Parameter System
Device and sensors help EMS, fire departments and military track five patient parameters MINNEAPOLIS, July 8, 2020 /PRNewswire/ — Nonin Medical, Inc. today announced the CO-Pilot™ Wireless Handheld Multi-Parameter System (H500) received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The CO-Pilot is a handheld device with wireless capabilities that helps […]
CHF Solutions and RenalSense Enter Distribution Partnership to Offer Ultrafiltration and Real-Time Renal Diagnostics
EDEN PRAIRIE, Minn., July 08, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) and RenalSense, Ltd., today announced the signing of a distribution agreement to offer complementary solutions for fluid management. The agreement allows CHF Solutions to market and sell RenalSense’s Clarity RMS™ (real-time monitoring system) in certain U.S. territories. Clarity RMS is […]
ViralClear Pharmaceuticals partners with Albany Molecular Research Inc. on the manufacture of merimepodib active pharmaceutical ingredient development for the potential treatment of COVID-19
Westport, CT, July 08, 2020 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) and its subsidiary, ViralClear Pharmaceuticals, Inc., today announced that it is partnering with Albany Molecular Research Inc., (AMRI), a leading global contract research, development and manufacturing organization (CDMO), for support in undertaking research to […]
SINOMED® Completes Last Patient Follow-Up of the PIONEER-III Pivotal US and Japanese Trial of the BuMA Supreme® Coronary Drug-Eluting Stent
TIANJIN, China, July 6, 2020 /PRNewswire/ — SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III, randomized global trial evaluating the BuMA Supreme Drug-Eluting Coronary Stent (DES). Once completed, the company plans to submit the data to the U.S. Food and Drug Administration and Japanese Pharmaceuticals […]



